Back to Search
SUSAN KAYE, M.D
M.D
Family Medicine Physician
NPI: 1760404115Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
25MA03789700(NJ)
Research & Publications (20)
Simple PCR-based method for synthesis of molecular calibrators and controls.
PMID 12560363·Clin Chem·2003
8-other
Characterization of ERG, AR and PTEN gene status in circulating tumor cells from patients with castration-resistant prostate cancer.
PMID 19339269·Cancer Res·2009
8-other
Observations of reduced electron Gyroscale fluctuations in national spherical torus experiment H-mode plasmas with large ExB flow shear.
PMID 19658873·Phys Rev Lett·2009
8-other
Methylenedioxymethamphetamine (MDMA)-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology.
PMID 19604654·Drug Alcohol Depend·2009
4-observational
Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.
PMID 19553641·N Engl J Med·2009
3-trial
A feasibility study of sequential doublet chemotherapy comprising carboplatin-doxorubicin and carboplatin-paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma.
PMID 19542250·Ann Oncol·2009
3-trial
Phase 3 randomised study of canfosfamide (Telcyta, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer.
PMID 19515553·Eur J Cancer·2009
3-trial
Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors.
PMID 19509256·Mol Cancer Ther·2009
3-trial
Is body mass index before middle age related to coronary heart disease risk in later life? Evidence from observational studies.
PMID 19506565·Int J Obes (Lond)·2009
1-meta
Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer.
PMID 19470933·J Clin Oncol·2009
3-trial
Safety and efficacy of patupilone in patients with advanced ovarian, primary fallopian, or primary peritoneal cancer: a phase I, open-label, dose-escalation study.
PMID 19451434·J Clin Oncol·2009
3-trial
Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?
PMID 19401696·Br J Cancer·2009
8-other
Correlation between electron transport and shear Alfvén activity in the National Spherical Torus Experiment.
PMID 19392207·Phys Rev Lett·2009
8-other
Penetrating and deep anterior lamellar keratoplasty for keratoconus: a comparison of graft outcomes in the United kingdom.
PMID 19661238·Invest Ophthalmol Vis Sci·2009
4-observational
Prospective validation of a prognostic score to improve patient selection for oncology phase I trials.
PMID 19332724·J Clin Oncol·2009
4-observational
PPM1D is a potential therapeutic target in ovarian clear cell carcinomas.
PMID 19293255·Clin Cancer Res·2009
8-other
Gyrokinetic studies on turbulence-driven and neoclassical nondiffusive toroidal-momentum transport and the effect of residual fluctuations in strong E x B shear.
PMID 19257365·Phys Rev Lett·2009
8-other
Revisiting the past: utilizing archival tissue for the detection and quantification of gene expression.
PMID 19222465·Br J Dermatol·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 33 OVERLOOK RD, 103
SUMMIT, NJ 07901 - Phone
- (908) 522-5700
Quick Facts
- NPI
- 1760404115
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile